SWOT Analysis for Nectar Lifesciences Ltd.

Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
Stock with Low PE (PE < = 10)

Negative Breakdown First Support (LTP < S1)
Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Low durability companies
Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks
Degrowth in Revenue and Profit
Declining Net Cash Flow : Companies not able to generate net cash
Companies with High Promoter Pledge
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Weak Momentum: Price below Short, Medium and Long Term Averages
Profit to Loss Companies
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
RSI indicating price weakness
Highest fall from 52 Week High
High promoter stock pledges
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Low durability companies

Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks

Degrowth in Revenue and Profit

Declining Net Cash Flow : Companies not able to generate net cash

Companies with High Promoter Pledge

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

RSI indicating price weakness

Highest fall from 52 Week High

High promoter stock pledges

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

FII / FPI or Institutions increasing their shareholding

Rising Delivery Percentage Compared to Prev Day
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Nectar Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Nectar Lifesciences Ltd. has 3 Strengths, 19 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Stock with Low PE (PE < = 10)

Negative Breakdown First Support (LTP < S1)

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Low durability companies

Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks

Degrowth in Revenue and Profit

Declining Net Cash Flow : Companies not able to generate net cash

Companies with High Promoter Pledge

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

RSI indicating price weakness

Highest fall from 52 Week High

High promoter stock pledges

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)